EP1890705
Notkun 24-nor-UDCA til að meðhöndla gallteppulifrarsjúkdóma
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.5.2005EP published:
11.11.2015EP application number:
05749537.6
EP translation filed:
29.1.2016Grant published:
15.2.2016EPO information:
European Patent Register
Max expiry date:
11.5.2025Expiry date:
11.5.2022
Title:
Use of 24-nor-UDCA for the treatment of cholestatic liver diseases
Timeline
Today
12.5.2005EP application
11.11.2015EP Publication
29.1.2016Translation submitted
15.2.2016Registration published
11.5.2022Expires
Owner
Name:
Medizinische Universität GrazAddress:
Auenbruggerplatz 2, 8036, Graz, AT
Inventor
Name:
TRAUNER, MichaelAddress:
Graz, AT
Name:
HOFMANN, AlanAddress:
La Jolla, California, US
Name:
FICKERT, PeterAddress:
Graz, AT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 31/575, A61P 1/16
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 9.3.2016
Expires: 11.5.2017
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 13
Paid: 27.3.2017
Expires: 11.5.2018
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 14
Paid: 8.3.2018
Expires: 11.5.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 15
Paid: 5.3.2019
Expires: 11.5.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 16
Paid: 2.3.2020
Expires: 11.5.2021
Payer: Patice ehf.
Number: 17
Paid: 12.2.2021
Expires: 11.5.2022
Payer: Patice ehf.